Filed: 2/17/2026ACC: 0001104659-26-015748
📋 What this filing means
AVORO CAPITAL ADVISORS LLC filed this quarterly 13F‑HR report disclosing 33 equity positions with a total reported market value of $10.17B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
33
Positions
$10.17B
Total AUM (reported)
159.20M
Total Shares
Allocation by class
COMMON$7.15B70.3%
SPONSORED ADR$1.92B18.9%
SPONSORED ADS$819.97M8.1%
ETF$256.05M2.5%
ORDINARY SHARES$22.86M0.2%
Portfolio Concentration
Top 3$3.41B33.5%
4–10$4.05B39.8%
11–25$2.50B24.6%
Rest$215.26M2.1%
Top 3 weight
33.5%
Top 10 weight
73.3%
Voting Authority Distribution
Total shares with voting rights: 159.20M
Sole
Full voting authority
159.20M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole33
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings33
Rows:
UNITED THERAPEUTICS CORP
SOLEShares2.61M
TypeSH
Market value$1.27B
12.48%
Sole
2.61M
Shared
0.00
None
0.00
ASCENDIS PHARMA
SOLEShares5.16M
TypeSH
Market value$1.09B
10.72%
Sole
5.16M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares1.81M
TypeSH
Market value$1.05B
10.35%
Sole
1.81M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares990K
TypeSH
Market value$832.54M
8.18%
Sole
990K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares2.89M
TypeSH
Market value$712.23M
7.00%
Sole
2.89M
Shared
0.00
None
0.00
ARROWHEAD PHARMACEUTICALS INC
SOLEShares10.63M
TypeSH
Market value$705.39M
6.93%
Sole
10.63M
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares7.47M
TypeSH
Market value$581.61M
5.72%
Sole
7.47M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares6.56M
TypeSH
Market value$455.94M
4.48%
Sole
6.56M
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares5.46M
TypeSH
Market value$393.47M
3.87%
Sole
5.46M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares14.56M
TypeSH
Market value$364.03M
3.58%
Sole
14.56M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares3.11M
TypeSH
Market value$310.30M
3.05%
Sole
3.11M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares12.22M
TypeSH
Market value$307.02M
3.02%
Sole
12.22M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares5.89M
TypeSH
Market value$298.21M
2.93%
Sole
5.89M
Shared
0.00
None
0.00
SPDR SERIES TRUST - S&P BIOTECH
SOLEShares2.10M
TypeSH
Market value$256.05M
2.52%
Sole
2.10M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares5.42M
TypeSH
Market value$243.12M
2.39%
Sole
5.42M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares4.35M
TypeSH
Market value$175.74M
1.73%
Sole
4.35M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares2.17M
TypeSH
Market value$172.84M
1.70%
Sole
2.17M
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares6.15M
TypeSH
Market value$147.17M
1.45%
Sole
6.15M
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares2.90M
TypeSH
Market value$134.27M
1.32%
Sole
2.90M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares10.78M
TypeSH
Market value$130.84M
1.29%
Sole
10.78M
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares21.70M
TypeSH
Market value$119.35M
1.17%
Sole
21.70M
Shared
0.00
None
0.00
MIND MEDICINE (MINDMED) INC
SOLEShares5M
TypeSH
Market value$66.95M
0.66%
Sole
5M
Shared
0.00
None
0.00
PTC THERAPEUTICS INC
SOLEShares685K
TypeSH
Market value$52.03M
0.51%
Sole
685K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares1.50M
TypeSH
Market value$46.68M
0.46%
Sole
1.50M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares1.33M
TypeSH
Market value$40.41M
0.40%
Sole
1.33M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
UNITED THERAPEUTICS CORPSOLE | Common | 2.61M | SH | $1.27B 12.48% | 2.61M | 0.00 | 0.00 |
ASCENDIS PHARMASOLE | Sponsored ADR | 5.16M | SH | $1.09B 10.72% | 5.16M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | Common | 1.81M | SH | $1.05B 10.35% | 1.81M | 0.00 | 0.00 |
ARGENX SESOLE | Sponsored ADR | 990K | SH | $832.54M 8.18% | 990K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | Common | 2.89M | SH | $712.23M 7.00% | 2.89M | 0.00 | 0.00 |
ARROWHEAD PHARMACEUTICALS INCSOLE | Common | 10.63M | SH | $705.39M 6.93% | 10.63M | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | Common | 7.47M | SH | $581.61M 5.72% | 7.47M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 6.56M | SH | $455.94M 4.48% | 6.56M | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | Common | 5.46M | SH | $393.47M 3.87% | 5.46M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 14.56M | SH | $364.03M 3.58% | 14.56M | 0.00 | 0.00 |
CELCUITY INCSOLE | Common | 3.11M | SH | $310.30M 3.05% | 3.11M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | Common | 12.22M | SH | $307.02M 3.02% | 12.22M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | Common | 5.89M | SH | $298.21M 2.93% | 5.89M | 0.00 | 0.00 |
SPDR SERIES TRUST - S&P BIOTECHSOLE | ETF | 2.10M | SH | $256.05M 2.52% | 2.10M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | Common | 5.42M | SH | $243.12M 2.39% | 5.42M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | Common | 4.35M | SH | $175.74M 1.73% | 4.35M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | Common | 2.17M | SH | $172.84M 1.70% | 2.17M | 0.00 | 0.00 |
UNIQURE NVSOLE | Common | 6.15M | SH | $147.17M 1.45% | 6.15M | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | Common | 2.90M | SH | $134.27M 1.32% | 2.90M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | Common | 10.78M | SH | $130.84M 1.29% | 10.78M | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | Common | 21.70M | SH | $119.35M 1.17% | 21.70M | 0.00 | 0.00 |
MIND MEDICINE (MINDMED) INCSOLE | Common | 5M | SH | $66.95M 0.66% | 5M | 0.00 | 0.00 |
PTC THERAPEUTICS INCSOLE | Common | 685K | SH | $52.03M 0.51% | 685K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | Common | 1.50M | SH | $46.68M 0.46% | 1.50M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | Common | 1.33M | SH | $40.41M 0.40% | 1.33M | 0.00 | 0.00 |
Page 1 of 2